The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Five Charged in U.S. with Stealing Secrets from GlaxoSmithKline

Five Charged in U.S. with Stealing Secrets from GlaxoSmithKline

January 23, 2016 • By Bill Berkrot

  • Tweet
  • Email
Print-Friendly Version / Save PDF

REUTERS—Five people, including two former GlaxoSmithKline researchers, were charged with a scheme to steal trade secrets from the British drugmaker for potential sale in China, according to indictments announced by the U.S. Attorney’s Office in Philadelphia on Wednesday.

You Might Also Like
  • Five Charged in $600 million California Healthcare Fraud Scheme
  • Past Secrets for the Future of Lupus
  • Regulatory Backlog in Emerging Nations Adding Years to Drug Approvals

The indictments include charges of conspiracy to steal trade secrets, conspiracy to commit wire fraud, conspiracy to commit money laundering, theft of trade secrets and wire fraud.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The stolen information on drugs for cancer and other serious diseases “potentially could be sold for millions of dollars to rival pharmaceutical companies and it would also be useful information for a start-up pharmaceutical company,” the complaint said.

The alleged conspirators established three corporations, one incorporated in Delaware and two likely in China, all using the name Renopharma, to sell the stolen information that could be used to reproduce Glaxo products and drugs in development, to competitors in China, according to the complaint.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

One of the five, Yu Xue, was a senior-level manager and biotechnology expert at a Glaxo research facility in Pennsylvania with access to a wide array of secret information. She was fired Jan. 6, 2016, Glaxo said.

She is accused of sending confidential information related to a dozen or more products to fellow “conspirators and others,” and also downloading a substantial amount of Glaxo intellectual property to pass along as part of the alleged scheme.

A motion aimed at keeping Yu Xue detained that was filed earlier this month said she “stole millions, perhaps billions, of dollars’ worth of trade secret and other confidential information from her employer, GlaxoSmithKline, to resell in China.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“Ms. Xue denies these allegations. She has pled not guilty and intends to contest these charges vigorously in court,” her attorney Peter Zeidenberg of Arent Fox said in an emailed statement.

The others named were Lucy Xi, a Glaxo scientist who left the company in November 2015, Tao Li, Yan Mei and Tian Xue, who is Yu Xue’s twin sister. The sister was used to hide proceeds of the crime, according to the complaint.

Mei is still being sought by authorities. Tao Li remains in custody, while the other three were arrested and released on bail, a spokeswoman for the U.S. Attorney’s office said.

Glaxo said it has been cooperating with authorities. “We do not believe the breach has had any material impact on the company’s business or R&D activity,” it said in a statement.

The alleged crimes took place between Jan. 1, 2012 and Dec. 28, 2015, the complaint said.

Pages: 1 2 | Multi-Page

Filed Under: Drug Updates, Pharma Co. News Tagged With: China, Drugs, GlaxoSmithKline, International, Legal

You Might Also Like:
  • Five Charged in $600 million California Healthcare Fraud Scheme
  • Past Secrets for the Future of Lupus
  • Regulatory Backlog in Emerging Nations Adding Years to Drug Approvals
  • Billionaire Insys Founder Charged in U.S. Opioid Bribe Case

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)